What is Checkpoint Surgical?
Founded in 2009, Checkpoint Surgical operates at the intersection of clinical research and medical device engineering. The company is dedicated to advancing the science and practice of peripheral nerve care, providing surgeons with innovative tools designed to improve patient recovery and surgical precision. Based in Cleveland, Ohio, the firm has cultivated a specialized niche, working closely with medical professionals to translate complex neurological challenges into actionable, technology-driven solutions.
The company's market position is defined by its commitment to education and research, which distinguishes it from traditional medical device manufacturers. By fostering deep collaborations with the surgical community, Checkpoint Surgical ensures that its product pipeline remains aligned with the evolving demands of modern healthcare, effectively bridging the gap between laboratory innovation and bedside application.
How much funding has Checkpoint Surgical raised?
Checkpoint Surgical has raised a total of $37.8M across 7 funding rounds:
Series A
$1.1M
Private Equity
$7.5M
Series B
$1.7M
Private Equity
$7.5M
Private Equity
$3.7M
Debt
$350K
Unspecified
$16M
Series A (2009): $1.1M with participation from JumpStart
Private Equity (2011): $7.5M, investors not publicly disclosed
Series B (2012): $1.7M supported by NDI Medical
Private Equity (2015): $7.5M featuring NDI Healthcare Fund and First Analysis
Private Equity (2016): $3.7M, investors not publicly disclosed
Debt (2020): $350K with participation from PPP
Unspecified (2021): $16M led by JumpStart NEXT Fund, First Analysis, RC Capital, and Mutual Capital Partners
Key Investors in Checkpoint Surgical
RC Capital
RC Capital is a growth equity firm focused on building high-potential healthcare companies by leveraging the interplay of medical devices, healthcare services, and healthcare IT.
First Analysis
First Analysis Securities operates as a venture capital firm offering private equity investments in health care, software, and technology companies.
Mutual Capital Partners
Mutual Capital Partners is a Cleveland-based venture capital fund that focuses on investing in early-stage software and medical device companies in the Midwest.
What's next for Checkpoint Surgical?
Looking ahead, the recent influx of capital is expected to accelerate the company's research and development initiatives, particularly in the realm of advanced neuro-monitoring and nerve repair technologies. As Checkpoint Surgical transitions into its next phase of maturity, the focus will likely shift toward expanding its commercial footprint and deepening its penetration into global surgical markets.
Strategic priorities will likely include the refinement of existing product lines and the exploration of new therapeutic applications for peripheral nerve injury. With the support of experienced growth equity partners, the company is well-equipped to navigate the regulatory and clinical hurdles inherent in the medical device industry, ensuring that its innovative solutions continue to set the standard for excellence in nerve care.
